SW
VRCA icon

SteelPeak Wealth’s Verrica Pharmaceuticals VRCA Stock Holding History

SteelPeak Wealth’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,600
Closed -$40.3K – 669
2025
Q2 		$40.3K Hold
7,600
– – ﹤0.01% 551
2025
Q1 		$33.6K Hold
7,600
– – ﹤0.01% 560
2024
Q4 		$53.2K Sell
7,600
-2,600
-25% -$28.6K ﹤0.01% 537
2024
Q3 		$148K Sell
10,200
-2,084
-17% -$93.9K 0.01% 466
2024
Q2 		$895K Sell
12,284
-1,510
-11% -$116K 0.04% 241
2024
Q1 		$817K Buy
13,794
+60
+0.4% +$3.31K 0.04% 244
2023
Q4 		$1.01M Buy
13,734
+35
+0.3% +$1.44K 0.06% 207
2023
Q3 		$532K Buy
13,699
+163
+1% +$8.28K 0.03% 251
2023
Q2 		$781K Hold
13,536
– – 0.05% 202
2023
Q1 		$880K Sell
13,536
-100
-0.7% -$6.05K 0.06% 173
2022
Q4 		$375K Buy
13,636
+170
+1% +$4.54K 0.03% 280
2022
Q3 		$393K Hold
13,466
– – 0.03% 288
2022
Q2 		$259K Buy
13,466
+125
+0.9% +$6.28K 0.02% 338
2022
Q1 		$1.08M Buy
13,341
+20
+0.2% +$1.65K 0.06% 180
2021
Q4 		$1.22M Buy
13,321
+5
+0% +$566 0.07% 161
2021
Q3 		$1.67M Buy
13,316
+20
+0.2% +$2.24K 0.11% 119
2021
Q2 		$1.5M Hold
13,296
– – 0.11% 134
2021
Q1 		$2.01M Hold
13,296
– – 0.16% 104
2020
Q4 		$1.53M Hold
13,296
– – 0.14% 119
2020
Q3 		$1.03M Buy
13,296
+60
+0.5% +$4.92K 0.11% 138
2020
Q2 		$1.46M Hold
13,236
– – 0.18% 94
2020
Q1 		$1.45M Hold
13,236
– – 0.23% 91
2019
Q4 		$2.1M Buy
+13,236
New +$1.95M 0.29% 74

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

SteelPeak Wealth's VRCA Position: Q3 2025 in Review

SteelPeak Wealth sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 7,600 shares — an estimated $40.3K sold.

SteelPeak Wealth first reported a position in VRCA in Q4 2019 and held it in 23 quarters. The position peaked at $2.1M in Q4 2019. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

  • SteelPeak Wealth reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • SteelPeak Wealth sold 7,600 Verrica Pharmaceuticals shares in Q3 2025, an estimated $40.3K.
  • SteelPeak Wealth first reported a position in Verrica Pharmaceuticals in Q4 2019 and held it in 23 quarters.
  • SteelPeak Wealth's Verrica Pharmaceuticals position peaked at $2.1M in Q4 2019.
  • 34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on SteelPeak Wealth's 13F filing for Q3 2025, filed 21 Oct 2025.